332 related articles for article (PubMed ID: 17597267)
1. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
[TBL] [Abstract][Full Text] [Related]
2. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.
Liang R; van den Hurk JV; Zheng C; Yu H; Pontarollo RA; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2005 Nov; 23(45):5252-62. PubMed ID: 16154245
[TBL] [Abstract][Full Text] [Related]
3. Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV.
Ridpath JF; Bolin SR
Virology; 1995 Sep; 212(1):259-62. PubMed ID: 7676642
[TBL] [Abstract][Full Text] [Related]
4. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
5. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
[TBL] [Abstract][Full Text] [Related]
6. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
[TBL] [Abstract][Full Text] [Related]
8. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
9. Retrospective genome analysis of a live vaccine strain of bovine viral diarrhea virus.
Bálint A; Baule C; Pálfi V; Belák S
Vet Res; 2005; 36(1):89-99. PubMed ID: 15610726
[TBL] [Abstract][Full Text] [Related]
10. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
[TBL] [Abstract][Full Text] [Related]
11. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
Brock KV; McCarty K; Chase CC; Harland R
Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
13. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
Platt R; Coutu C; Meinert T; Roth JA
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.
Thomas C; Young NJ; Heaney J; Collins ME; Brownlie J
Vaccine; 2009 Apr; 27(17):2387-93. PubMed ID: 19428855
[TBL] [Abstract][Full Text] [Related]
15. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
[TBL] [Abstract][Full Text] [Related]
16. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
17. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
[TBL] [Abstract][Full Text] [Related]
18. Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies.
van Drunen Littel-van den Hurk S; Lawman Z; Wilson D; Luxembourg A; Ellefsen B; van den Hurk JV; Hannaman D
Vaccine; 2010 Sep; 28(39):6445-54. PubMed ID: 20670907
[TBL] [Abstract][Full Text] [Related]
19. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
20. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
